DLD Asset Management »

Arrowhead Pharmaceuticals shares owned by DLD Asset Management

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $408k 5.0k 81.56

More positions owned by DLD Asset Management

Echostar Corp Note 3.875%11/3 (Principal)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Stride Note 1.125% 9/0 (Principal)
Centrus Energy Corp Note 2.250%11/0 (Principal)
Akamai Technologies Note 0.250% 5/1 (Principal)
On Semiconductor Corp Note 5/0 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Marathon Digital Holdings In Put Option (MARA)
Eli Lilly & Co. Call Option (LLY)
Firstenergy Corp Note 3.625% 1/1 (Principal)
Encore Cap Group Note 4.000% 3/1 (Principal)
Patrick Inds Note 1.750%12/0 (Principal)
Super Micro Computer Com New Put Option (SMCI)
Merit Med Sys Note 3.000% 2/0 (Principal)

View all positions for DLD Asset Management

Top funds holding Arrowhead Pharmaceuticals

BlackRock
venBio Select Advisor
FMR
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Norges Bank Investment Management
Invesco
Geode Capital Management
Fred Alger Management
Baker Bros. Advisors
Susquehanna International
Siren
Vestal Point Capital
Henderson Group

View all funds holding Arrowhead Pharmaceuticals